atomoxetine hydrochloride has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Constantinescu, CC; Mirbolooki, MR; Mukherjee, J; Pan, ML | 1 |
1 other study(ies) available for atomoxetine hydrochloride and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.
Topics: Adipose Tissue, Brown; Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Blood Glucose; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Male; Norepinephrine Plasma Membrane Transport Proteins; Obesity; Propranolol; Propylamines; Radionuclide Imaging; Rats; Rats, Sprague-Dawley | 2013 |